Reliable Ultra-Low Freezers for the Storage of Cancer Biomarkers

Reliable Ultra-Low Freezers for the Storage of Cancer Biomarkers

The use of tumour markers to diagnose, assess prognosis, and select a suitable cancer treatment has become possible due to the development of inexpensive and user-friendly molecular analysis tools such as the polymerase chain reaction (PCR). Maintaining the integrity of biomarkers during their processing and storage is therefore of critical importance to accurately diagnose and give prognosis of many different diseases, including cancers.

To safely store samples for research or clinical use, freezing procedures are used to arrest the degradation of biomarkers used for the identification of these diseases. However, the long-term stability of these molecules depends upon their long-term storage conditions provided by specialised equipment depending on the storage temperatures required. When it comes to safely store important cancer biomarkers in fluid, cell, and tissue biospecimens, ultra-low temperature storage is often used.

Background

Analysing frozen tissue and body fluid samples has become standard practice for suspected cancers following recent breakthroughs in practical applications of molecular diagnostics, which allow to detect cancer-associated biological molecules more commonly known as biomarkers.

Featured Partners

An accurate assessment of biomarkers in a biospecimen is nowadays considered essential for making an accurate diagnosis. Therefore, the key biological features of the sample need to be maintained during its processing and storage as such biologicals contain vital molecules required for a variety of tests which can degrade over time and at certain temperatures.

As the activity of these molecules is dependent on the dynamics between them and the ambient temperature, reducing the proteins’ activity by decreasing the temperature is a mechanism that has now been used for decades to reliably maintain biospecimens.

Biomarkers in oncology

In oncology, biomarker testing identifies genes, proteins, and other substances that can reveal information about a cancer since each type of it displays a different pattern of them. The data can then be used to diagnose or classify the cancer, estimate the prognosis, or select an appropriate treatment. Tumour markers are divided into two groups: tumour markers found in tissues and circulating tumour markers found in body fluids.

Tumour tissue (or cell) markers

Ultra-low temperature frozen tissue is used for cancer biomarker testing as it provides high-quality nucleic acids (DNA and RNA) and proteins for the testing procedures. However, the suitability of tissue biospecimens for biomarker testing is highly dependent on how the biospecimens are processed and stored, but generally speaking ultra-low freezers are the equipment of choice when looking for a solution to reliably store these samples.

Circulating tumour markers

Tumours release a certain amount of their fragments into the peritumoral area. These fragments can be individual malignant cells, clusters, proteins, or nucleic acids. As a result, these molecules can be found in multiple body fluids, including serum, saliva, blood and urine, and can be used as tumour indicators. It is for this reason that very often blood plasma is analysed to find these biomarkers.

Therefore, plasma storage conditions are significant preanalytical factors influencing circulating tumour marker analysis outcomes. Generally speaking, these samples are stored at temperatures ranging from -80°C to -20°C, with the more rigid temperatures offering better sample quality over time.

Reliable Ultra-Low Freezers for modern cancer research

Ultra-Low Freezers are essential for the storage of samples in cancer research and are especially important in maintaining the stability and quality of biomarkers. Hence, when selecting ultra-low freezers to purchase and use, the performance and the reliability of these units should be carefully considered. The flexibility in offering varying set points can help medical professionals choose the right storage temperature depending on the type of biomarkers being frozen and the length of the storage required.

Moreover, the Ultra-Low Freezers must maintain a uniform temperature inside their cabinets to best maintain the samples, while superior door opening recovery (DoR) and hold over times will help ensure their safety even during adverse events. Certifications such as the EU MDR ensure compliance with regulations that govern the production of quality medical devices. These, along with 24/7 real-time monitoring systems can ensure that specimens are always stored in the most ideal conditions. Furthermore, energy-efficient operations and green refrigerants will ensure that laboratories will be able to achieve considerable sustainability levels.

Conclusion

Specimens stored at ultra-low temperatures are generally preferred over other types in cancer biomarker testing because most of these biomarkers, such as nucleic acids and protein molecules, are prone to degradation due to a variety of factors. Moreover, biospecimens also contain degradative molecules whose activities are greatly influenced by temperature.

As a result, appropriate storage temperatures that render these enzymes inactive must be chosen to preserve the biomarkers. Various studies have demonstrated that if biospecimens are used mainly for DNA and protein analysis, long-term storage at temperatures between −70°C or −80°C can be effective. It is for this reason that reliable Ultra-Low Freezers should be used to store these delicate samples: by providing temperature flexibility and sample safety with these products, researchers can use them to store their biologicals for extended periods of time. Moreover, Ultra-Low Freezers that employ natural green refrigerants and that possess all the required certifications should be prioritised to always ensure the samples’ safety.

advertisement